°í´ë ±¸·Îº´¿ø, ÈäºÎ¿Ü°ú ½Äµµ¾Ï ¼ö¼úÆÀ
Çмú´ëȸ ÃÖ¿ì¼ö¿¬Á¦»ó ¼ö»ó
½Äµµ¾Ï¿¡¼ º¸´Ù È¿°úÀûÀÎ °¨½Ã¸²ÇÁÀý ÃßÀû ¹°Áú ºñ±³¿¬±¸
°í´ë ±¸·Îº´¿ø ÈäºÎ¿Ü°ú ½Äµµ¾Ï ¼ö¼úÆÀ(±èÇö±¸, °µÎ¿µ, ÃÖ¿µÈ£ ±³¼ö)ÀÌ ´ëÇѱâ°ü½Äµµ°úÇÐȸ Çмú´ëȸ¿¡¼ ‘ÃÖ¿ì¼ö¿¬Á¦»ó’À» ¼ö»óÇß´Ù. ±èÇö±¸ ±³¼ö´Â Áö³ 3¿ù 19ÀÏ ¼¿ï´ëÇб³º´¿ø ÀÓ»óÀÇÇבּ¸¼Ò °´ç¿¡¼ °³ÃÖµÈ Ãá°èÇмú´ëȸ¿¡¼ ÀÌ Çмú»óÀ» ¼ö»óÇÏ°í »óÀå°ú »ó±ÝÀ» ¼ö¿©¹Þ¾Ò´Ù.
À̹ø¿¡ ¼ö»óÇÑ ±è ±³¼öÀÇ ³í¹®Àº “½Äµµ¾Ï¿¡ ÀÖ¾î¼ Å×Å©³×Ƭ 99m ³×¿À¸¶³ë½Ç Àΰ£ Ç÷û¾ËºÎ¹Î(99m-Tc MSA)°ú 99m Tc-ÇÇÅ×ÀÌÆ® °£ÀÇ °¨½Ã¸²ÇÁÀý ½Äº°ÀÇ Â÷ÀÌÁ¡( Difference of sentinel Lymph Node Identification between Technetium-99m Neomannosyl Human Serum Albumin(99mTc-MSA) and 99m Tc-Phytate in Esophageal cancer)"À̶ó´Â Á¦¸ñÀ¸·Î ½Äµµ¾Ï¿¡¼ °¨½ÃÀý ¹ß°ßÀ» À§ÇÑ ‘ÇÇÅ×ÀÌÆ®’¿Í ‘³×¿À¸¶³ë½Ç ¼ö¿ë±â ¹ÙÀεù ¿¡ÀÌÀüÆ®ÀÎ 99m Å×Å©³×Ƭ ³×¿À¸¶³ë½Ç Àΰ£ Ç÷û¾ËºÎ¹Î(MSA)’À» ºñ±³ÇÏ´Â ³»¿ëÀÌ´Ù. ¿¬±¸°á°ú¿¡ µû¸£¸é Ãʱâ´Ü°è ½Äµµ¾Ï¿¡¼ ÇÇÅ×ÀÌÆ®¿Í MSA ¸ðµÎ ½Å·ÚÇÒ¸¸ÇÑ ÇßÁö¸¸, ƯÈ÷ ÇÇÅ×ÀÌÆ®º¸´Ù´Â MSA°¡ º¸´Ù ÀÚÁÖ Á¤È®ÇÏ°Ô °¨½ÃÀýÀ» ã¾Æ³½ °ÍÀ¸·Î ³ªÅ¸³µ´Ù.
°¨½Ã¸²ÇÁÀý(Sentinel Lymph Node, SLN)À̶õ Á¾¾çÀÌ ¸²ÇÁÀýÀ» ÅëÇØ Á÷Á¢ ÀüÀ̵Ǵ °æ¿ì °¡Àå óÀ½ µµ´ÞÇÏ´Â ¸²ÇÁÀýÀ» ¸»ÇÑ´Ù. °¨½Ã¸²ÇÁÀý »ý°ËÀº ¾ÏÁ¶Á÷¿¡ ¸²ÇÁÀý¿°»ö»ö¼Ò¸¦ ÁÖÀÔÇØ °¨½Ã¸²ÇÁÀýÀ» ã¾Æ³½ ÈÄ À̸¦ ÀýÁ¦, °Ë»çÇØ ¾Ï¼¼Æ÷ÀÇ ÀüÀÌ¿©ºÎ¸¦ È®ÀÎÇÏ´Â ¹æ¹ýÀÌ´Ù. ¸¸¾à ¿©±â¿¡¼ ¾ÏÀÌ ¹ß°ßµÇ¸é ¸²ÇÁÀý Àüü¿¡µµ ¾ÏÀÌ ÀüÀ̵ƴٰí ÃßÁ¤ÇÏ°í ÁÖÀ§ ¸²ÇÁÀý Àüü¸¦ ÀýÁ¦ÇÏÁö¸¸, ¾ÏÀÌ ¹ß°ßµÇÁö ¾ÊÀ¸¸é ¸²ÇÁÀý ÀüÀÌ´Â ³ªÅ¸³ªÁö ¾Ê´Â °ÍÀ¸·Î ÆÇ´ÜÇÏ°í ¸²ÇÁÀý ÀýÁ¦¸¦ ÃÖ¼ÒÈ ÇÒ ¼ö ÀÖ´Ù.
°í´ë ±¸·Îº´¿ø ÈäºÎ¿Ü°ú´Â ÀÌ °¨½Ã¸²ÇÁÀý »ý°ËÀ» ±¹³»¿¡ óÀ½À¸·Î µµÀÔÇßÀ¸¸ç, ÃÖ±Ù ´ÙÇÐÁ¦ ¿¬±¸¸¦ ÅëÇØ Àû¿ë°¡´ÉÇÑ ¼ö¼ú¹üÀ§¸¦ ³ÐÇô³ª°¡°í ÀÖ´Ù.
ÇÑÆí, ´ëÇѱâ°ü½Äµµ°úÇÐȸ ÃÖ¿ì¼ö¿¬Á¦»óÀº ±Ý¹ø Çмú´ëȸ¿¡ ¹ßÇ¥µÈ ¿¬Á¦Áß ÃÖ¿ì¼ø ¿¬Á¦¿¡°Ô, ÃÖ¿ì¼ö ³í¹®»óÀº Àü³âµµ ´ëÇѱâ°ü½Äµµ°úÇÐȸÁö¿¡ ¹ßÇ¥µÈ ³í¹® Áß ÃÖ¿ì¼ö ³í¹®¿¡°Ô ¼ö¿©µÇ´Â °ÍÀ¸·Î, ¿ÃÇØ ½Å¼³µÇ¾î ±èÇö±¸ ±³¼ö¿Í ´Ü±¹´ëÀÇ´ë À̺ñÀÎÈÄ°ú Á¤ÇÊ»ó ±³¼ö°¡ °¢°¢ ÃÖÃÊ ¼ö»óÀÚ°¡ µÆ´Ù.
|